DOXA.ST
Price:
$0.4595
Market Cap:
$590.70M
Doxa AB (publ), a dental company, develops, manufactures, and commercializes bioceramic dental products under the Ceramir brand worldwide. It offers Crown & Bridge, a dental cement that is used for permanent cementing of crowns and bridges. The company was founded in 1987 and is based in Uppsala, Sweden.
Industry
Medical - Instruments & Supplies
IPO Date
2014-04-07
Stock Exchange
STO
Ticker
DOXA.ST
According to Doxa AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is -0.28. This represents a change of -80.12% compared to the average of -1.41 of the last 4 quarters.
The mean historical PE Ratio of Doxa AB (publ) over the last ten years is -2.65. The current -0.28 PE Ratio has changed 955.42% with respect to the historical average. Over the past ten years (40 quarters), DOXA.ST's PE Ratio was at its highest in in the June 2024 quarter at 34.54. The PE Ratio was at its lowest in in the December 2019 quarter at -118.16.
Average
-2.65
Median
-3.08
Minimum
-27.26
Maximum
15.57
Discovering the peaks and valleys of Doxa AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 205.42%
Maximum Annual PE Ratio = 15.57
Minimum Annual Increase = -558.46%
Minimum Annual PE Ratio = -27.26
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -0.33 | -107.22% |
| 2023 | 4.54 | -116.65% |
| 2022 | -27.26 | -275.06% |
| 2021 | 15.57 | -327.23% |
| 2020 | -6.85 | -42.02% |
| 2019 | -11.82 | -192.22% |
| 2018 | 12.81 | -558.46% |
| 2017 | -2.80 | -60.33% |
| 2016 | -7.05 | 110.01% |
| 2015 | -3.35 | 205.42% |
The current PE Ratio of Doxa AB (publ) (DOXA.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-7.68
5-year avg
-2.87
10-year avg
-2.65
Doxa AB (publ)’s PE Ratio is greater than FluoGuide A/S (-9.36), less than ADDvise Group AB (publ) (212.55), greater than Bactiguard Holding AB (publ) (-30.39), less than Cantargia AB (publ) (7.35), greater than Q-linea AB (publ) (-0.78), greater than Enzymatica AB (publ) (-7.40), greater than Corline Biomedical AB (-16.64), greater than Infant Bacterial Therapeutics AB (publ) (-8.09), greater than Moberg Pharma AB (publ) (-1.70),
| Company | PE Ratio | Market cap |
|---|---|---|
| -9.36 | $478.07M | |
| 212.55 | $916.02M | |
| -30.39 | $646.48M | |
| 7.35 | $1.03B | |
| -0.78 | $137.58M | |
| -7.40 | $400.51M | |
| -16.64 | $396.75M | |
| -8.09 | $623.57M | |
| -1.70 | $437.11M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Doxa AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Doxa AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Doxa AB (publ)'s PE Ratio?
How is the PE Ratio calculated for Doxa AB (publ) (DOXA.ST)?
What is the highest PE Ratio for Doxa AB (publ) (DOXA.ST)?
What is the 3-year average PE Ratio for Doxa AB (publ) (DOXA.ST)?
What is the 5-year average PE Ratio for Doxa AB (publ) (DOXA.ST)?
How does the current PE Ratio for Doxa AB (publ) (DOXA.ST) compare to its historical average?